In order to assess the potential in combining oncolytic virotherapy with immune checkpoint inhibition, melanoma cell lines Sk29Mel-1 and Mz7Mel were first analyzed for expression of the immune checkpoint proteins CTLA-4, PD-1, and PD-L1. The gene discussed is CTLA4; the disease is melanoma.